Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial

Raphaèle Seror; Gabriel Baron; Eric Hachulla; Michel Debandt; Claire Larroche; Xavier Puéchal; François Maurier; Benoît de Wazieres; Thomas Quéméneur; Philippe Ravaud; Xavier Mariette

doi:10.1136/annrheumdis-2013-203586

Article info

Clinical and epidemiological research

Extended report

Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial

Authors

Raphaèle Seror Department of Rheumatology, Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, Le Kremlin Bicêtre, France PubMed articles Google scholar articles
Gabriel Baron Faculty of Medicine, Assistance Publique–Hopitaux de Paris, Hôtel Dieu Hospital, Centre of Clinical Epidemiology, University of Paris Descartes, Paris, France PubMed articles Google scholar articles
Eric Hachulla Department of Internal Medicine, National Referral Centre for Rare Systemic Auto-immune Diseases, Hôpital Claude Huriez, Université de Lille 2, Lille, France PubMed articles Google scholar articles
Michel Debandt Department of Rheumatology, CHU de La Meynard, Fort de France, France PubMed articles Google scholar articles
Claire Larroche Department of Internal Medicine, Hôpital Avicenne, APHP, Bobigny, France PubMed articles Google scholar articles
Xavier Puéchal Department of Rheumatology, Hôpital du Mans, Le Mans, France National Referral Centre for Rare Systemic Auto-immune Diseases, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France PubMed articles Google scholar articles
François Maurier Department of Internal Medicine, HP-Metz Site HSB, Metz, France PubMed articles Google scholar articles
Benoît de Wazieres Department of Internal Medicine and Gerontology, CHU de Nîmes, Nîmes, France PubMed articles Google scholar articles
Thomas Quéméneur Department of Internal Medicine, Centre Hospitalier Valenciennes, Valenciennes, France PubMed articles Google scholar articles
Philippe Ravaud Faculty of Medicine, Assistance Publique–Hopitaux de Paris, Hôtel Dieu Hospital, Centre of Clinical Epidemiology, University of Paris Descartes, Paris, France PubMed articles Google scholar articles
Xavier Mariette Department of Rheumatology, Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, Le Kremlin Bicêtre, France PubMed articles Google scholar articles

Correspondence to Dr Xavier Mariette, Department of Rheumatology, Hôpital Bicêtre, 78 rue du Général Leclerc, Le Kremlin Bicêtre 94275, France; xavier.mariette{at}bct.aphp.fr

View Full Text

Citation

Seror R, Baron G, Hachulla E, et al

Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial

Annals of the Rheumatic Diseases 2014;73:2074-2081.

Publication history

Received March 7, 2013
Revised June 9, 2013
Accepted July 9, 2013
First published July 29, 2013.

Online issue publication

February 26, 2018

Article Versions

Previous version (25 October 2017).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password